Two Sigma Advisers
CRTX

Two Sigma Advisers’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Two Sigma Advisers’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-12,150
Closed -$115K – 2661
2013
Q3 		$115K Sell
12,150
-1,000
-8% -$9.01K ﹤0.01% 2000
2013
Q2 		$106K Buy
+13,150
New +$111K ﹤0.01% 2069

Other funds holding CRTX

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HA
Havens Advisors New York $39.3M AUM 80.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return

Two Sigma Advisers's CRTX Position: Q4 2013 in Review

Two Sigma Advisers sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q4 2013, closing a stake of 12,150 shares — an estimated $115K sold.

Two Sigma Advisers first reported a position in CRTX in Q2 2013 and held it in 2 quarters. The position peaked at $115K in Q3 2013. 62 funds tracked by Wall St. Rank hold CRTX as of Q4 2013.

  • Two Sigma Advisers reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q4 2013 after selling out during the quarter.
  • Two Sigma Advisers sold 12,150 CORNERSTONE THERAPEUTICS INC shares in Q4 2013, an estimated $115K.
  • Two Sigma Advisers first reported a position in CORNERSTONE THERAPEUTICS INC in Q2 2013 and held it in 2 quarters.
  • Two Sigma Advisers's CORNERSTONE THERAPEUTICS INC position peaked at $115K in Q3 2013.
  • 62 funds tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q4 2013.

Based on Two Sigma Advisers's 13F filing for Q4 2013, filed 14 Feb 2014.